Determination of Serum Insulin in Patients with Islet Cell Tumours of the Pancreas

Author(s):  
J. Groen ◽  
A. F. Willebrands ◽  
H. G. van der Geld ◽  
R. E. Bolinger
1984 ◽  
Vol 104 (4_Supplb) ◽  
pp. S22-S23
Author(s):  
R. GÜNTHER ◽  
K. J. KLOSE ◽  
K. RÜCKERT ◽  
F. P. KUHN ◽  
H. J. KLOTTER

1985 ◽  
Vol 29 (2) ◽  
pp. 142-146
Author(s):  
M. PUVANESWARY ◽  
MASOOD AFZAL

1994 ◽  
Vol 49 (5) ◽  
pp. 295-303 ◽  
Author(s):  
C.M.P. King ◽  
R.H. Reznek ◽  
J.E. Dacie ◽  
J.A.H. Wass

2021 ◽  
Author(s):  
Islet and Pancreas Analysis Core

This SOP defines the assay method used by the Vanderbilt Diabetes Center Islet and Pancreas Analysis (IPA) Core for quantitative determination of the islet cell composition and islet cell mass of mouse pancreas by immunofluorescent staining.


2020 ◽  
Author(s):  
Foroogh Forghani ◽  
Mahboube Mirhashemi

Abstract Background: PUD is a common and important type of gastrointestinal disease. Determination of contributing factors for PUD is an important issue for the development of preventive approaches. In this study, the association of Peptic Ulcer Disease with Obesity and Serum Insulin and Lipid Profile was studied.Methods: In this case-control study in Modarres Hospital in Tehran in 2019 among 170 consecutive subjects including 90 patients with PUD and 80 cases without it were enrolled and sampling tools were checklists. Serum Insulin and Lipid Profile and BMI were compared across the groupsResults: The results in this study demonstrated that Serum Insulin and Lipid Profile and BMI had no statistically significant difference between those patients with and without presence of PUD (P > 0.05).Conclusion: This study showed no statistically significant difference between those patients with and without the presence of PUD from points of Serum Insulin and Lipid Profile and BMI.


Sign in / Sign up

Export Citation Format

Share Document